Trigemina Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Out of Business

Trigemina General Information

Description

Developer of non-narcotic analgesic drug products intended to develop novel, non-opioid, non-sedating, cognition neutral neurological therapies. The company's drugs are made up of novel naso-cerebral formulations for pain therapy that are delivered to through the nasal-cerebral pathway, enabling people to get relief from chronic migraine and other neuropathic pain.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1036 Country Club Drive
  • Suite 200
  • Moraga, CA 94556
  • United States
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Corporate Office
  • 1036 Country Club Drive
  • Suite 200
  • Moraga, CA 94556
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trigemina Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 05-Aug-2020 Completed Out of Business
7. Later Stage VC (Series A1) 14-Apr-2014 Completed Generating Revenue
6. Grant 17-Jun-2013 Completed Generating Revenue
5. Later Stage VC 12-Apr-2012 Completed Generating Revenue
4. Early Stage VC 17-Nov-2010 Completed Startup
3. Early Stage VC 22-Dec-2009 Completed Startup
2. Grant 01-Jan-2009 $444K $2.41M Completed Startup
1. Early Stage VC (Series A) 09-May-2007 $2.41M $2.41M Completed Startup
To view Trigemina’s complete valuation and funding history, request access »

Trigemina Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-narcotic analgesic drug products intended to develop novel, non-opioid, non-sedating, cognition neutral
Drug Discovery
Moraga, CA
12 As of 2015

Boston, MA
 

Bethlehem, PA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Trigemina Competitors (15)

One of Trigemina’s 15 competitors is Centrexion Therapeutics, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrexion Therapeutics Venture Capital-Backed Boston, MA
Azevan Pharmaceuticals Venture Capital-Backed Bethlehem, PA
Xalud Therapeutics Venture Capital-Backed New York, NY
Rein Therapeutics Formerly VC-backed Austin, TX
Phoenix PharmaLabs Venture Capital-Backed Salt Lake City, UT
You’re viewing 5 of 15 competitors. Get the full list »

Trigemina Patents

Trigemina Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024038482-A Labeled oxytocin and method of manufacture and use Inactive 01-Mar-2018
WO-2019169342-A1 Labeled oxytocin and method of manufacture and use Inactive 01-Mar-2018
JP-2025015576-A Magnesium-containing oxytocin formulations and methods of use Pending 12-Apr-2016
WO-2017180781-A1 Magnesium-containing oxytocin formulations and methods of use Inactive 12-Apr-2016
JP-2022079671-A Magnesium-containing oxytocin preparation and method of use Inactive 12-Apr-2016 A61K38/095
To view Trigemina’s complete patent history, request access »

Trigemina Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trigemina FAQs

  • When was Trigemina founded?

    Trigemina was founded in 2006.

  • Where is Trigemina headquartered?

    Trigemina is headquartered in Moraga, CA.

  • What is the size of Trigemina?

    Trigemina has 12 total employees.

  • What industry is Trigemina in?

    Trigemina’s primary industry is Drug Discovery.

  • Is Trigemina a private or public company?

    Trigemina is a Private company.

  • What is Trigemina’s current revenue?

    The current revenue for Trigemina is .

  • How much funding has Trigemina raised over time?

    Trigemina has raised $7.61M.

  • Who are Trigemina’s competitors?

    Centrexion Therapeutics, Azevan Pharmaceuticals, Xalud Therapeutics, Rein Therapeutics, and Phoenix PharmaLabs are some of the 15 competitors of Trigemina.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process